Here are the The Effects of Imeglimin on Muscle Strength in Patients with Type 2 Diabetes: A Prospective Cohort Study journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.
The effects of imeglimin wikipedia, the effects of imeglimin on muscle strength in roblox, the effects of imeglimin on muscle strength information, the effects of imeglimin on muscle strength in patients with emphysema, the effects of climate change, the effects of imeglimin 500mg, the effects of social media on mental health, the effects of imeglimin on muscle strength in patients with cirrhosis.
The Effects of Imeglimin on Muscle Strength in Patients with Type 2 Diabetes: A Prospective Cohort Study
Introduction: A bidirectional relationship has been observed between type 2 diabetes mellitus and sarcopenia, especially among older adults. While previous studies have reported that imeglimin improves mitochondrial function, they have not assessed its effects on muscle strength in patients with type 2 diabetes. Therefore, we aimed to investigate the effects of imeglimin on muscle strength in patients with type 2 diabetes.
Methods: In this prospective cohort study, we recruited consenting patients with type 2 diabetes (20–75 years). Changes in lean body mass (LBM), fat mass, quadriceps muscle strength, and grip strength from baseline (week 0) to week 24 were evaluated and compared between patients treated with imeglimin therapy (group I) and those who did not take imeglimin (controls, group C).
Results: We recruited 27 patients treated with imeglimin (group I) and 29 controls (group C), and 50 of them completed the study (gro up I: n = 23; group C: n = 27). The change in LBM, total body fat mass, or skeletal muscle index from baseline to week 24 did not differ significantly between the two groups. However, group I exhibited a significantly higher percent change in quadriceps knee extension strength from baseline to week 24 than group C (13 ± 19% and 2.1 ± 14%, p = 0.022). Conversely, the difference in percent change in grip strength was not significant. Multivariable analysis showed that imeglimin use was significantly associated with a percent change in quadriceps knee extension strength, independent of age, sex, body mass index, and skeletal mass index (β = 0.325, p = 0.0014). Conclusions: Imeglimin positively affected muscle strength in patients with type 2 diabetes without altering LBM. Therefore, imeglimin exerts a unique effect on skeletal muscles in humans. Further randomized controlled trials are needed to validate these findings. Trial Registration: This research was registered in the Univers ity Hospital Medical Information Network (UMIN, UMIN000054715). © The Author(s) 2024.
Authors : Oyanagi T.; Kawanabe S.; Tsukiyama H.; Nishine A.; Nakamura Y.; Nakagawa T.; Kanou M.; Kubota J.; Tsunemi S.; Yokota K.; Sone M.
Source : Adis
Article Information
| Year | 2024 |
| Type | Article |
| DOI | 10.1007/s13300-024-01639-x |
| ISSN | 18696953 |
| Volume | 15 |
You can download the article here
If You have any problem, contact us here